Stock listing

A1W50M Stock Price, News, Filings & Events — Fate Therapeutics, Inc.

Selected listing: A1W50M · LS · EUR · DE

The selected listing A1W50M:LS represents Fate Therapeutics, Inc., a biotechnology company focused on developing cell-based immunotherapies for cancer and immune disorders. The company is advancing its proprietary induced pluripotent stem cell (iPSC) technology to create off-the-shelf cellular therapies. Recent news includes updates on clinical trials and partnerships aimed at enhancing its therapeutic offerings. Investors can find relevant filings and upcoming events that may impact the company's market presence and growth potential.

A1W50M:LSEURDEUpdated July 24, 2026
Fate Therapeutics, Inc. logo
Ticker
A1W50M:LS
Asset type
Stock
Market cap
$280.9M
Sector
Health Technology
Industry
Biotechnology
Exchange
LS
Currency
EUR

Fate Therapeutics, Inc. A1W50M:LS stock context

The selected listing A1W50M:LS represents Fate Therapeutics, Inc., a biotechnology company focused on developing cell-based immunotherapies for cancer and immune disorders. The company is advancing its proprietary induced pluripotent stem cell (iPSC) technology to create off-the-shelf cellular therapies. Recent news includes updates on clinical trials and partnerships aimed at enhancing its therapeutic offerings. Investors can find relevant filings and upcoming events that may impact the company's market presence and growth potential.

Research Fate Therapeutics, Inc.

Alternate listings